| Literature DB >> 27689729 |
Imran Khan1, Mushtaq A Tantray1, Mohammad Sarwar Alam1, Hinna Hamid2.
Abstract
Glycogen synthase kinase-3 is a multi-functional serine-threonine kinase and is involved in diverse physiological processes, including metabolism, cell cycle, and gene expression by regulating a wide variety of known substrates like glycogen synthase, tau-protein and β-catenin. Aberrant GSK-3 has been involved in diabetes, inflammation, cancer, Alzheimer's and bipolar disorder. In this review, we present an overview of the involvement of GSK-3 in various signalling pathways, resulting in a number of adverse pathologies due to its dysregulation. In addition, a detailed description of the small molecule inhibitors of GSK-3 with different mode of action discovered or specifically developed for GSK-3 has been presented. Furthermore, some clues for the future optimization of these promising molecules to develop specific drugs inhibiting GSK-3, for the treatment of associated disease conditions have also been discussed. Copyright ÂEntities:
Keywords: ATP; Alzheimer's disease; Diabetes; Glycogen synthase kinase; Kinases; Phosphorylation
Mesh:
Substances:
Year: 2016 PMID: 27689729 DOI: 10.1016/j.ejmech.2016.09.058
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514